Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease

European Journal of Clinical Nutrition

Volumn 58, Issue 3, 2004, Pages 481-487

  Lee, B J ^a   Huang, M C ^b   Chung, L J ^c   Cheng, C H ^a   Lin, K L ^d   Su, K H ^e   Huang, Y C ^c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHIENKUO TECHNOLOGY UNIVERSITY   (Taiwan)

Author keywords

Coronary artery disease; Folic acid; Homocysteine; Supplementation; Vitamin B12; Vitamin B6

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PLACEBO; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORRELATION COEFFICIENT; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENERAL HOSPITAL; HEART CATHETERIZATION; HUMAN; HYPERHOMOCYSTEINEMIA; LOW DRUG DOSE; MALE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; TABLET FORMULATION; TAIWAN; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERIOSCLEROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B 6;

EID: 1842527939     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601834     Document Type: Article

References (31)

1. Araki A & Sako Y (1987): Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422, 43-52.
2. Arnadottir M, Brattstrom L, Simonsen O, Thysell B, Hultberg B, Andersson A & Nilsson-Ehle P (1993): The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and fasting plasma homocysteine concentrations in dialysis patients. Clin. Nephrol. 40, 236-240.
3. 12 status is inversely associated with plasma homocysteine in young women with C677T and/or A1298C methylenetetrahydrofolate reductase polymorphisms. J. Nutr. 132, 1872-1878.
4. Bates CJ, Pentieva KD, Matthews N & Macdonald A (1999): A simple, sensitive and reproducible assay for pyridoxal 5′ -phosphate and 4-pyridoxic acid in human plasma. Chin. Chim. Acta 280, 101-111.
5. Bautista LE, Arenas IA, Penuela A & Martinez LX (2002): Total plasma homocysteine level and risk of cardiovascular disease: A meta-analysis of prospective cohort studies. J. Clin. Epidemiol. 55, 882-887.
6. 6 supplementation. Ann. Nutr. Metab. 45, 255-258.
7. Boushey CJ, Beresford SA, Omenn GS & Motulsky AG (1995): A quantitative assessment of fasting plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274, 1049-1057.
8. Brattström L, Israelsson B, Norrving B, Bergqvist D, Thorne J, Hultberg B & Hamfelt A (1990): Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 81, 51-60.
9. Brouwer IA, van Dusseldorp M, Thomas CM, Duran M, Hautvast JG, Eskes TK & Steegers-Theunissen RP (1999): Low-dose folic acid supplementation decreases fasting plasma homocysteine concentrations: A randomized trial. Am. J. Clin. Nutr. 69, 99-104.
10. 6, and lipid in cardiovascular disease. Nutrition 18, 595-598.
11. Chasan-Taber L, Selhub J, Rosenberg IH, Malinow MR, Terry P, Tishler PV, Willett W, Hennekens CH & Stampfer MJ (1996): A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J. Am. Coll. Nutr. 15, 136-143.
12. Clarke R & Armitage J (2000): Vitamin supplements and cardiovascular risk: Review of the randomized trials of homocysteine-lowering vitamin supplements. Semin. Thromb. Hemost. 26, 341-348.
13. Dudman NP, Wilcken DE, Wang J, Lynch JF, Macey D & Lundberg P (1993): Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler. Thromb. 13, 1253-1260.
14. Food and Nutrition Board - Institute of Medicine (1998): Dietary Reference Intakes. Thiamin, Riboflavin, Niacin, Vitamin B-6, Folate, Vitamin B-12, Pantothenic acid, Biotin, and Choline. Washington, DC: National Academy Press.
15. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW & Thacker SB (2002): Homocyst(e)ine andAcardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int. J. Epidemiol. 31, 59-70.
16. Genest Jr JJ, McNamara JR, Salem DN, Wilson PW, Schaefer EJ & Malinow MR (1990): Plasma homocyst(e)ine levels in men with premature coronary artery disease. J. Am. Coll. Cardiol. 16, 1114-1119.
17. Lee BJ, Lin PT, Liaw YP, Chang SJ, Cheng CH, Huang YC (2003): Homocysteine and risk of coronary artery disease: Folate is the important determinant of fasting plasma homocysteine concentration. Nutrition 19, 577-583.
18. Lindenbaum J, Savage DG, Stabler SP & Allen RH (1990): Diagnosis of cobalamin deficiency: II. relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am. J. Hematol. 34, 99-107.
19. Mansoor MA, Kristensen O, Hervig T, Bates CJ, Pentieva K, Vefring H, Osland A, Berge T, Drablos PA, Hetland O & Rolfsen S (1999): Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals. Oral doses of vitamin B6 reduce concentrations of serum folate. Scand. J. Clin. Lab. Invest. 59, 139-146.
20. McKinley MC, McNulty H, McPartlin J, Strain JJ, Pentieva K, Ward M, Weir DG & Scott JM (2001): Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am. J. Clin. Nutr. 73, 759-764.
21. Miller JW, Ribaya-Mercado JD, Russell RM, Shepard DC, Morrow FD, Cochary EF, Sadowski JA, Gershoff SN & Selhub J (1992): Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations. Am. J. Clin. Nutr. 55, 1154-1160.
22. Morrison HI, Schaubel D, Desmeules M & Wigle DT (1996): Serum folate and risk of fatal coronary heart disease. JAMA 275, 1893-1896.
23. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, Kottke-Marchant K, Savon SR, Selhub J & Nissen SE (1995): Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 92, 2825-2830.
24. Rydlewicz A, Simpson JA, Taylor RJ, Bond CM & Golden MHN (2002): The effect of folic acid supplementation on fasting plasma homocysteine in an elderly population. Q. J. Med. 95, 27-35.
25. Selhub J & Miller JW (1992): The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am. J. Clin. Nutr. 55, 131-138.
26. Serfontein WJ, Ubbink JB, de Villiers LS, Rapley CH & Becker PJ (1985): Plasma pyridoxal-5-phosphate level as risk index for coronary artery disease. Atherosclerosis 55, 357-361.
27. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV & Hennekens CH (1992): A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268, 877-881.
28. Ubbink JB, Vermaak WJH, van der Merwe A, Becker FJ, Delport R & Potgieter HC (1994): Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124, 1927-1933.
29. Ubbink JB, van der Merwe A, Delport R, Allen RH, Stabler SP, Riezler R & Vermaak WJ (1996): The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J. Clin. Invest. 98, 177-184.
30. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH & Willett WC (1996): Homocysteine metabolism and risk of myocardial infarction: Relation with vitamin B-6, B-12, and folate. Am J. Epidemiol. 143, 845-859.
31. Woodring MJ & Storvick CA (1970): Effect of pyridoxine supplementation on glutamic-pyruvic transaminase, and in vitro stimulation in erythrocytes of normal women. Am. J. Clin. Nutr. 23, 1385-1395.